Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise the predominant genetic cause of Parkinson's disease (PD). G2019S, the most common amino acid substitution activates the kinase two- to threefold. This has motivated the development of LRRK2...
Main Authors: | Martin Steger, Francesca Tonelli, Genta Ito, Paul Davies, Matthias Trost, Melanie Vetter, Stefanie Wachter, Esben Lorentzen, Graham Duddy, Stephen Wilson, Marco AS Baptista, Brian K Fiske, Matthew J Fell, John A Morrow, Alastair D Reith, Dario R Alessi, Matthias Mann |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2016-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/12813 |
Similar Items
-
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
by: Martin Steger, et al.
Published: (2017-11-01) -
The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System
by: Tomoki Kuwahara, et al.
Published: (2020-03-01) -
The Regulation of Rab GTPases by Phosphorylation
by: Lejia Xu, et al.
Published: (2021-09-01) -
Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
by: Ga Ram Jeong, et al.
Published: (2018-02-01) -
An Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s Disease
by: Tadayuki Komori, et al.
Published: (2023-11-01)